Process for preparing nucleoside prodrugs
AssigneeNuCana plc
InventorsChristopher McGuigan (Deceased), Fabrizio Pertusati
Life of this patent
Estimating the term…
Abstract
A process for preparing phosphoramidates of nucleosides where a desired enantiomer, having regard to the asymmetric chiral center of the phosphorus atom P, is provided in an enriched amount. The process comprises admixing a nucleoside with a phosphorochloridate in the presence of a catalyst comprising a metal salt selected from the group consisting of salts of Cu, Fe, La and Yb.
Claims11
1-37. (canceled)
A method of treating cancer, wherein the method comprises administering to a human patient in need thereof a therapeutically effective amount of a composition comprising a compound of the formula:
- or a pharmaceutically acceptable salt thereof, wherein the ratio of the RP diastereomer to the Se diastereomer is in the range from 1:20 to 0:100.
Dependencies are inferred from the claim text.